tirzepatide portugal Switch to in T2D More Effective Than Upping Dulaglutide Dose Tirzepatide: Injection Home Kit –

The simple answer

Methods In this retrospective cohort study, 125 474 adults with overweight or obesity newly initiated treatment with a dual-labeled GLP-1 RA (liraglutide, semaglutide, or tirzepatide) between January 1, 2018, and December 31, 2023, with a baseline body mass index of 27 or more, an available weight measurement within 60 days before initiation, and regular care in the year before initiation were identified using electronic health record data from a collective of US health care systems

The numan take Retatrutide is shaping up to be a promising obesity treatment

Research has not demonstrated significant differences in efficacy between morning and evening administration for once-daily or once-weekly formulations, provided the medication is taken regularly

If youre curious about what to expect on the scale and beyond, read: Before and After Weight Loss: What Results Can You Expect